Target intelligence / Profile preview

Lean body mass preservation (None (no standard abbreviation for this as a molecular target))

Target
None (no standard abbreviation for this as a molecular target)
Molecular classification
None (not a molecule, receptor, enzyme, or protein; refers to a physiological outcome or process)
01

Overview

Lean body mass preservation refers to the maintenance or minimization of the loss of non-fat tissues—including skeletal muscle, bone, organs, and connective tissues—during periods when overall body weight is reduced through diet, medication, illness, or aging. It is not a single molecule or druggable biological target but rather an important clinical goal because maintaining adequate lean tissue supports metabolic health, physical function/mobility, immune response capacity, bone density protection against osteoporosis/frailty/fractures in later life stages. Strategies proven effective at preserving lean body mass include increased dietary protein intake above standard recommendations (~1.2–1.6 g/kg/day), regular resistance exercise/training programs tailored by age/ability level—and careful monitoring when using potent anti-obesity medications that may otherwise accelerate both fat and non-fat losses if unaccompanied by these supportive measures.

Other names
Muscle preservationLean mass retentionFat-free mass maintenance
02

Mechanism of action

Not applicable—lean body mass preservation is an outcome influenced by interventions such as: Increased dietary protein intake supports muscle protein synthesis over breakdown during caloric deficit or aging. Resistance training stimulates hypertrophy and helps maintain/increase muscle tissue even during periods of weight loss or aging.

03

Biological functions

Maintenance of muscle protein synthesisPrevention of sarcopeniaSupport of metabolic rate and basal energy expenditurePreservation of physical function and mobility
04

Disease associations

Sarcopenia (age-related muscle loss)Obesity and weight managementFrailty in elderly populations
05

Safety considerations

Excessive calorie restriction without adequate exercise/protein can accelerate muscle/lean tissue loss leading to frailty/sarcopenia especially in older adultsSome pharmacologic agents that promote rapid weight loss may increase risk for excessive lean tissue depletion if not combined with protective strategies like resistance training/protein supplementation
06

Interacting drugs

GLP-1 receptor agonists (e.g., semaglutide) (associated with lean body mass loss during weight reduction; strategies to mitigate this include adjunct therapies but these do not directly \"target\" lean body mass itself)

1 more in the full profile.

07

Biomarkers

Dual-energy X-ray absorptiometry (DEXA) scans for quantifying changes in fat-free/lean tissueBioelectrical impedance analysis (BIA)Muscle strength/function tests (e.g., grip strength)

Beyond the preview

Go deeper on Lean body mass preservation (None (no standard abbreviation for this as a molecular target)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lean body mass preservation (None (no standard abbreviation for this as a molecular target)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call